Publications
À ce jour, elle est l'auteur et la co-auteure de chapitres de livres en oncologie gynécologique et d'environ 150 articles publiés dans des revues scientifiques nationales et internationales. Son indice H est de 30.
Dernières publications
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med. 2019 Sep 28
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators
Lire la suite
Management of recurrent ovarian cancer: when platinum-based regimens are not a therapeutic option.
Int J Gynecol Cancer. 2019 Nov;29(9):1431-1436. doi: 10.1136/ijgc-2019-000624. Epub 2019 Sep 18
Bergamini A, Bocciolone L, Fodor A, Candiani M, Mangili G.
Lire la suite
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease.
J Ultrasound Med. 2019 Aug 29
Cavoretto P, Cioffi R, Mangili G, Petrone M, Bergamini A, Rabaiotti E, Valsecchi L, Candiani M, Seckl MJ
Lire la suite
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study.
Gynecol Oncol. 2019 Aug;154(2):323-327.
Bergamini A, Cormio G, Ferrandina G, Lorusso D, Giorda G, Scarfone G, Bocciolone L, Raspagliesi F, Tateo S, Cassani C, Savarese A, Breda E, De Giorgi U, Mascilini F, Candiani M, Kardhashi A, Biglia N, Perrone AM, Pignata S, Mangili G.
Lire la suite
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study.
Gynecol Oncol. 2018 Dec;151(3):449-452
Mangili G, Cioffi R, Danese S, Frigerio L, Ferrandina G, Cormio G, Rabaiotti E, Scarfone G, Gadducci A, Bergamini A, Pisano C, Candiani M
Lire la suite
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study.
Eur J Surg Oncol. 2018
Bergamini A, Ferrandina G, Candiani M, Cormio G, Giorda G, Lauria R, Perrone AM, Scarfone G, Breda E, Savarese A, Frigerio L, Gadducci A, Mascilini F, Maneschi F, Cassani C, Marchetti C, Cecere SC, Biglia N, De Giorgi U, Raspagliesi F, Lorusso D, Mangili G
Lire la suite
Reproductive Outcomes After Gestational Trophoblastic Neoplasia. A Comparison Between Single-Agent and Multiagent Chemotherapy: Retrospective Analysis From the MITO-9 Group.
Int J Gynecol Cancer. 2018 Feb;28(2):332-337
Cioffi R, Bergamini A, Gadducci A, Cormio G, Giorgione V, Petrone M, Rabaiotti E, Pella F, Candiani M, Mangili G.
Lire la suite
Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
Hum Reprod. 2018 Feb 1;33(2):181-187.
Peccatori FA, Mangili G, Bergamini A, Filippi F, Martinelli F, Ferrari F, Noli S, Rabaiotti E, Candiani M, Somigliana E.
Lire la suite
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.
Eur J Surg Oncol. 2019
Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA RARECARENet Working Group.
Lire la suite
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
J Clin Oncol. 2017 Oct 10;35(29):3347-3353.
Pignata S, Scambia G, Bologna A, Signoriello S, Vergote IB, Wagner U, Lorusso D, Murgia V, Sorio R, Ferrandina G, Sacco C, Cormio G, Breda E, Cinieri S, Natale D, Mangili G, Pisano C, Cecere SC, Di Napoli M, Salutari V, Raspagliesi F, Arenare L, Bergamini A, Bryce J, Daniele G, Piccirillo MC, Gallo C, Perrone F.
Lire la suite
Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT).
Ann Oncol. 2017 Aug 1;28(8):1910-1916.
De Giorgi U, Richard S, Badoglio M, Kanfer E, Bourrhis JH, Nicolas-Virelizier E, Vettenranta K, Lioure B, Martin S, Dreger P, Schuler MK, Thomson K, Scarpi E, Rosti G, Selle F, Mangili G, Lanza F, Bregni M; Solid Tumours Working Party (STWP) of the EBMT.
Lire la suite
Long-acting recombinant follicle-stimulating hormone in random-start ovarian stimulation protocols for fertility preservation in women with cancer.
Acta Obstet Gynecol Scand. 2017 Aug;96(8):949-953
Sarais V, Paffoni A, Pagliardini L, Filippi F, Martinelli F, Mangili G, Candiani M, Papaleo E.
Lire la suite
Fertility preservation in women with borderline ovarian tumours.
Cancer Treat Rev. 2016 Sep;49:13-24
Mangili G, Somigliana E, Giorgione V, Martinelli F, Filippi F, Petrella MC, Candiani M, Peccatori F.
Lire la suite
The role of staging and adjuvant chemotherapy in stage I Malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Ann Oncol. 2017
Mangili G, Sigismondi C, Lorusso D, Cormio G, Candiani M, Scarfone G, Mascilini F, Gadducci A, Mosconi AM, Scollo P, Cassani C, Pignata S, Ferrandina G.
Lire la suite
Management of bilateral malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Int J Gynecol Cancer. 2015 Feb;25(2):203-7.
Sigismondi C, Scollo P, Ferrandina G, Candiani M, Angioli R, Viganò R, Scarfone G, Mangili G.
Lire la suite